- Home
- MBLY vs RVMD Comparison
MBLY vs RVMD Comparison
Compare MBLY & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBLY | RVMD |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 7.5B |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MBLY | RVMD |
|---|---|---|
| Price | $10.62 | $78.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 18 |
| Target Price | $18.94 | ★ $77.11 |
| AVG Volume (30 Days) | ★ 4.2M | 2.2M |
| Earning Date | 01-29-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,938,000,000.00 | N/A |
| Revenue This Year | $15.90 | N/A |
| Revenue Next Year | $7.88 | $714.50 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.61 | N/A |
| 52 Week Low | $10.74 | $29.17 |
| 52 Week High | $22.51 | $81.49 |
Technical Indicators
Market Signals| Indicator | MBLY | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 33.51 | 73.74 |
| Support Level | $11.17 | $77.54 |
| Resistance Level | $11.88 | $80.44 |
| Average True Range (ATR) | 0.42 | 2.41 |
| MACD | 0.01 | -0.54 |
| Stochastic Oscillator | 2.31 | 68.85 |
Price Performance
Historical ComparisonAbout MBLY Mobileye Global Inc.
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. The company's reportable operating segment are Mobileye and Others. Its solutions comprise Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System & Vehicles. It derives maximum revenue from Mobileye Segment.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.